Patents
Patents for C07D 261 - Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings (11,459)
02/2008
02/07/2008WO2008016692A2 Chemical compounds
02/07/2008US20080033181 Process for the preparation of Zonisamide and the intermediates thereof
02/07/2008US20080032982 2-{2-[3-(4-chlorophenyl)acryloyl]-4-methylphenoxy}-4-phenylbutanoic acid; Peroxisome Proliferator Activated Receptors (PPAR); diabetes, dyslipidemia and/or atherosclerosis
02/07/2008CA2659473A1 Chemical compounds
02/06/2008EP1884511A1 Aromatic ether compounds,preparation and usage thereof
02/06/2008EP1883633A2 Heterocyclic anti-viral compounds comprising metabolizable moieties and their uses
02/06/2008CN100366605C Compounds to treat alzheimer's disease
02/05/2008US7326790 Diphenylisoxazole compounds and hydro isomers thereof
02/05/2008US7326789 E.g., 2-(4-Chloro-phenylsufonylamino)-4,5-dimethoxy-N-(4-(thiomorpholine-4-sulfonyl)-phenyl)-benzamide; cardiovascular disorders; hypotensive agents; angina pectoris, cardiac insufficiency, thrombolytic agents; atherosclerosis; activating soluble guanylate cyclase to adjust a disturbed cyclic GMP balance
02/05/2008US7326696 Amino-methyl substituted tetracycline compounds
01/2008
01/31/2008WO2008012027A1 Insecticidal compounds
01/31/2008US20080027228 Substituted thioacetamides
01/31/2008US20080027096 Novel Pharmaceutical Compositions
01/31/2008US20080027068 Heterocyclic compounds and thrombopoietin receptor activators
01/31/2008US20080027059 Substituted isoxazolines, pharmaceutical compositions containing same, methods of preparing same, and uses of same
01/31/2008US20080026061 Crystalline N-(4-chloro-3-methyl-5-isoxazolyl)-2-[2-methyl-4.5-(methylenedioxy)phenylacetyl]-thiophene-3-sulfonamide
01/31/2008CA2657247A1 Compounds which modulate the cb2 receptor
01/30/2008EP1881967A1 Substituted benzo(d)isoxazol-3-yl amine compounds as analgesics
01/30/2008CN101115713A HIV protease inhibitors
01/30/2008CN101113137A Intermidiate for preparing 1,2-oxygen nitrogen heterocyclic-2-alkene acylbenzene and its preparation
01/24/2008WO2008011110A2 Di-amino-substituted heterocyclic compounds and methods of use
01/24/2008WO2008009695A1 Rearrangement of spirolactams
01/24/2008WO2007096261A3 Process for the preparation of dioxane derivatives
01/24/2008US20080021027 Novel benzimidazole derivatives
01/24/2008US20080021022 (5-(4-Chlorophenyl)isoxazol-4-yl)(3-(pyridin-3-yl)pyrrolidin-1-yl)methanone; enzyme inhibitor of Hydroxysteroid dehydrogenases; treatment of diabetes, obesity
01/24/2008CA2658190A1 Di-amino-substituted heterocyclic compounds and methods of use
01/17/2008WO2008006561A1 Substituted isoxalines, pharmaceutical compositions containing same, methods of preparing same, and uses of same
01/17/2008WO2007096647A3 Diaryl compounds as non-steroidal inhibitors of 17-beta hydroxysteroid dehydrogenase and/or steroid sulphatase for the treatment of oestrogen-related diseases such as hormone dependent breast cancer
01/17/2008WO2007080159A3 Pyridine-, isoxazole, thiophenecarboxamide compounds having activity at the glycine transporter glyt1 and uses thereof
01/17/2008US20080015190 Inhibitors of Histone Deacetylase
01/17/2008US20080015169 Amino-methyl substituted tetracycline compounds
01/17/2008CA2657336A1 Substituted isoxalines, pharmaceutical compositions containing same, methods of preparing same, and uses of same
01/16/2008EP1878730A1 Substituted isoxazolines, pharmaceutical compositions containing the same, methods of preparing the same, and uses of the same
01/16/2008EP1877390A1 Benzisoxazole piperazine compounds and methods of use thereof
01/16/2008CN100361982C Isoxazoline derivative and herbicide comprising the same as active ingredient
01/15/2008US7319163 N-[3,5-Dibromo-4-(3-bromobenzyloxy)benzoyl]benzenesulphonamide for example; cardiac arrhythmias, thyrotoxicosis and subclinical hyperthyroidism
01/15/2008US7319152 5-Aryl-indan-1-one and analogs useful as progesterone receptor modulators
01/15/2008US7319150 Method for preparing styryl pyrazole, isoxazole and isothiazole derivatives
01/15/2008US7319109 4-(Substituted phenoxy or anilino)-3-phenyl- or phenylalkylisoxazoles: 3-{[(4-{[3-(2,6-Dichlorophenyl)-5-isopropylisoxazol-4-yl]methoxy}-2-methylphenyl)-(methyl)amino]methyl}benzoic acid; cardiovascular disease, cholestatic liver disease, organ fibrosis, triglycerides, increasing high density lipoprotein
01/15/2008US7319104 hPPARs activators
01/15/2008US7319097 Treatment of type II diabetes with benzenesulfonamide substituted with an N-heterocycle: N-[2-amino-5-(1,4-diazepan-1-yl)phenyl]benzenesulfonamide, N-[4-amino-5-(piperazinyl)phenyl]benzenesulfonamide, 3-amino-4-(5-methyl-2,5-diaza-bicyclo[2.2.1]hept-2-yl)-N-phenyl-benzenesulfonamide hydrochloride
01/15/2008US7319096 Antiarrhythmia agents; liver disorders; skin disorders
01/10/2008WO2008003141A1 Therapeutic compounds
01/10/2008US20080009535 Inhibitors of phosphodiesterase type-IV
01/10/2008CA2656851A1 Substituted cinnamoyl anthranilate compounds exhibiting anti-fibrotic activity
01/09/2008EP1874741A1 Azole derivatives in the form of lipase and phospholipase inhibitors
01/09/2008CN101103007A 酰胺化合物 Amide compounds
01/09/2008CN101103003A Novel heterocycle derivatives useful as selective androgen receptor modulators (SARMS)
01/09/2008CN101103000A Carbazole, carboline, and indole derivatives useful in the inhibition of VEGF production
01/09/2008CN100360523C 1,2,4 furodazole-phenoxyalkyl substituted derivative of iso-oxazole, preparation method and anti virus application
01/09/2008CN100360507C Inhibition of raf kinase using substituted heterocyclic ureas
01/08/2008US7317028 Antitumor agents; autoimmune disease; skin disorders; anticancer agents
01/08/2008CA2228060C Isoxazole and crotonamide derivatives and their use as pharmaceuticals and diagnostics
01/03/2008US20080004415 Non-linear optically active molecules, their synthesis, and use
01/03/2008US20080004331 for hepatitis C; histone deacetylase inhibitors; N-hydroxy-4-{[(naphthyl-carbonylamino]alkoxy}benzamides; anticarcinogenic agent; acute promyelocytic leukemia; cell-cycle arrest in late G1 phase or at the G2/M transition
01/03/2008US20080004251 Novel Pharmaceutical Compositions Comprising Agonists of the Thyroid Receptor
01/02/2008CN101098697A Compouns, compositions, processes of making, and methods of use related to inhibiting macrophage migration inhibitory factor
01/02/2008CN100358888C Novel guanidine mimics as factor Xa inhibitors
01/01/2008US7314872 Selective in presence of at least one other cathepsin isozyme; such as morpholine-4-carboxylic acid {2-cyclopentyl-1--[2-(4-methoxy-phenylamino)-1--methyl-ethylcarbamoyl]-ethyl}-amide
12/2007
12/27/2007WO2007047305A8 Methods of treating amyloidosis using cyclopropyl derivative aspartyl protease inhibitors
12/27/2007US20070299263 Hydroxy Alkyl Amines
12/27/2007US20070299080 Benzamide derivatives and uses related thereto
12/27/2007US20070299074 Guanidine Compounds, and Use Thereof as Binding partners for 5-Ht5 Receptors
12/27/2007US20070299073 Imidazolyl derivatives
12/26/2007EP1869054A2 Condensed isoxaline derivatives as inhibitors of phosphodiesterase type-iv
12/26/2007CN101094830A Fused bicyclic carboxamide derivatives for use as CXCR2 inhibitors in the treatment of inflammation
12/21/2007WO2007118323B1 Isoxazole derivatives as calcium channel blockers
12/21/2007WO2007085451A3 3,5-di (aryl or heteroaryl) isoxazoles and 1, 2, 4-oxadiazoles as s1p1 receptor agonists, immunosuppresssive and anti -inflammatory agents
12/21/2007CA2655146A1 Benzamide derivatives and uses related thereto
12/20/2007US20070293542 Selective Cox-2 Inhibitors
12/20/2007US20070293540 for hepatitis C; histone deacetylase inhibitors; N-hydroxy-4-{[(naphthyl-carbonylamino]alkoxy}benzamides; anticarcinogenic agent; acute promyelocytic leukemia; cell-cycle arrest in late G1 phase or at the G2/M transition
12/20/2007US20070293423 Compounds, Methods and Formulations for the Oral Delivery of a Glucagon-Like Peptide (Glp)-1 Compound or a Melanocortin-4 Receptor (Mc4) Agonist Peptide
12/19/2007EP1867633A1 Polyamine analogues as therapeutic and diagnostic agents
12/19/2007EP1866298A2 Hydroxysteroid dehydrogenase inhibitors
12/19/2007EP1866277A2 Sulfonyl containing compounds as cysteine protease inhibitors
12/19/2007EP1664031B1 Adamantane and azabicyclo-octane and nonane derivatives process of their preparation and their use as dpp-iv inhibitors
12/19/2007EP1490062B1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
12/19/2007EP1032556B1 Pharmaceutically active compounds and methods of use
12/19/2007EP1005341B1 Il-8 receptor antagonists
12/19/2007CN101090895A Aryl sulphonamide modulators
12/19/2007CN101090883A Substituted hydroxyethylamines
12/18/2007US7309802 Preparation of isoxazolin-3-ylacylbenzene
12/18/2007US7309800 Biphenylcarboxylic amide derivatives as p38 kinase inhibitors
12/13/2007WO2007141269A1 Novel receptor antagonists and their methods of use
12/13/2007US20070287739 Aryl-4-ethynyl-isoxazole derivatives
12/13/2007US20070286801 2-[18F]fluoro-4-(5-methyl-3-phenylisoxazol-4-yl)benzenesulfonamide; imaging probes (11C, 123I, 125I, 73Se, 76Br, 77Br, 18F, deuterium) for positron emission tomography (PET); greater sensitivity, resolution; quantitative measurement; antiinflammatory agent, disorder with elevated cyclooxygenase-2 level
12/12/2007CN101087755A Substituted aryl acylthioureas and related compounds; inhibitors of viral replication
12/11/2007CA2393271C Retroviral protease inhibiting compounds
12/06/2007WO2007138996A1 Novel crystal of 3-[5-[4-(cyclopentyloxy)-2- hydroxybenzoyl]-2-[(3-hydroxy-1,2-benzisoxazol-6- yl)methoxy]phenyl]propionic acid
12/06/2007WO2007137980A1 Nitrated heterocyclic compounds as endothelin receptor antagonist
12/06/2007WO2007137954A1 Aryl-4-ethynyl-isoxazole derivatives
12/06/2007US20070281952 Arylsulfonylnaphthalene Derivatives As 5Ht2a Antagonists
12/06/2007US20070281916 Substituted isoxazolines and their use as antibacterial agents
12/06/2007CA2652939A1 Novel crystal of 3-[5-[4-(cyclopentyloxy)-2- hydroxybenzoyl]-2-[(3-hydroxy-1,2-benzisoxazol-6-yl)methoxy]phenyl]propionic acid
12/06/2007CA2652636A1 Nitrated heterocyclic compounds as endothelin receptor antagonist
12/06/2007CA2651857A1 Aryl-4-ethynyl-isoxazole derivatives
12/05/2007EP1861382A1 Fused aromatic compounds having anti-diabetic activity
12/05/2007EP1861381A1 Novel 3-aryl-1,2-benzisoxazole derivatives, compostions containing same and use thereof
12/05/2007EP1720848B1 Derivatives of alkylpiperazine- and alkylhomopiperazine- carboxylates, preparation method thereof and use of same as faah enzyme inhibitors
12/05/2007CN101084178A (benzyloxy-biphenyl) acetic acids and derivatives thereof
1 ... 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 ... 115